About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Houston | 164 Studies

Clinical Trials COPDHouston

COPD Clinical Trials in Houston

Find 164 clinical trials for copd near Houston, Texas. Connect with research centers in your area.

All COPD trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 164 trials

CompletedPivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 InflammationPrimary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate-or severe Chronic Obstructive Pulmonary Disease (COPD) as measured…NCT03930732·Andalusia, Alabama and 274 others

PreviousPage 2 of 9Next

COPD Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsThe purpose of this Phase III study is to evaluate the efficacy and safety of tozorakimab administered subcutaneously (SC) in adult participants with symptomatic COPD with a…NCT06040086·Birmingham, Alabama and 367 others

CompletedLong-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)The purpose of this study is to evaluate the safety, tolerability and efficacy of inhaled aclidinium bromide at two dose levels in patients with moderate to severe, stable chronic…NCT01044459·Birmingham, Alabama and 112 others

CompletedA Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPDThe purpose of this study is to determine if ensifentrine is safe and effective for the treatment of patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).NCT04542057·Alabaster, Alabama and 129 others

TerminatedA One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPDA One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics with Chronic Obstructive Pulmonary Disease.NCT00138671·Glendale, Arizona and 87 others

CompletedA Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsThe purpose of this study is to compare a combination asthma drug (Symbicort) with its two components, budesonide and formoterol, taken individually or in combination, and with…NCT00206154·Birmingham, Alabama and 211 others

CompletedSafety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPDPhase 3 , open-label, randomized study to evaluate the safety and efficacy of the Lilly/Alkermes inhaled insulin system compared to injected insulin in type 1 and type 2 diabetes…NCT00157339·Montgomery, Alabama and 100 others

Active not recruitingVideo Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to compare the efficacy and safety of a real time video telehealth pulmonary rehabilitation intervention with standard of care in patients…NCT05119556·Birmingham, Alabama and 14 others

CompletedEffectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPDThe symptoms associated with COPD include overproduction of mucus and inflammation in the lungs.NCT00648245·Glendale, Arizona and 13 others

CompletedEfficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPDThe objective of this study is to evaluate the effect of inhaled tiotropium bromide on trough FEV1 and to assess the cardiac effects through 12-lead and Holter ECG monitoring in…NCT00239460·Birmingham, Alabama and 11 others

CompletedLong Term Safety Study of NVA237 vs QAB149 in COPD PatientsThe purpose of the study is to provide long term safety data of NVA237. This study will assess the safety and tolerability of a single dose strength of NVA237.NCT01697696·Gulf Shores, Alabama and 60 others

RecruitingEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypeThis is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in…NCT07190209·Chandler, Arizona and 313 others

CompletedFluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary DiseaseThe objective of this study is to demonstrate that, when added to tiotropium (TIO), fluticasone propionate/salmeterol combination (FSC) DISKUS 250/50 significantly increases…NCT01124422·Birmingham, Alabama and 26 others

WithdrawnAccessing Mobility Using Wearable SensorsThis study will examine whether wearable sensors can be used to track changes in cognitive-motor performance in response to a disease or an intervention.NCT04306588·Houston, Texas

CompletedA Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPDThe purpose of this study is to determine if SYMBICORT® delivered via a pressurized metered-dose inhaler, referred to as a pMDI, is effective in preventing COPD exacerbations.NCT00419744·Jasper, Alabama and 139 others

CompletedStudy to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)Primary Objective: Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with…NCT04701983·Birmingham, Alabama and 231 others

CompletedA Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary DiseaseThis study is intended to determine the safety and tolerance of regadenoson in subjects with asthma or chronic obstructive pulmonary disease.NCT00862641·Montgomery, Alabama and 47 others

CompletedEfficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)The overall objective of this study is to assess the efficacy and safety of treatment with PT003 (GFF MDI), PT005 (FF MDI), PT001 (GP MDI), and open-label tiotropium bromide…NCT01854645·Andalusia, Alabama and 138 others

UnknownVibration Response Imaging (VRI) in Dyspnea Patients Presenting to the EDFor the patient with acute dyspnea in the ED, early differentiation between CHF and non-CHF causes is essential for proper management.NCT01206621·Newark, Delaware and 7 others

RecruitingDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)Depemokimab is being developed as a treatment for individuals with moderate to severe COPD.NCT06961214·Sheffield, Alabama and 192 others

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia